Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer
- 1 November 2016
- journal article
- review article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 124, 992-1003
- https://doi.org/10.1016/j.ejmech.2016.10.032
Abstract
No abstract availableKeywords
Funding Information
- AIMST University, Kedah, Malaysia
This publication has 97 references indexed in Scilit:
- Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factorsBritish Journal of Cancer, 2011
- Prognostic impact of thymidine phosphorylase expression in breast cancer – Comparison of microarray and immunohistochemical dataEuropean Journal of Cancer, 2010
- Structures of native human thymidine phosphorylase and in complex with 5-iodouracilBiochemical and Biophysical Research Communications, 2009
- Thymidine phosphorylase as a prognostic factor in renal cell carcinomaInternational Urology and Nephrology, 2009
- Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug designBiochemical Journal, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cellsOncogene, 2002
- Molecular Basis for the Inhibition of Hypoxia-Induced Apoptosis by 2-Deoxy-d-riboseBiochemical and Biophysical Research Communications, 2002
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971